Orchard Therapeutics plc
ORTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $68 | $56 | $55 | $19 |
| Short-Term Investments | $75 | $164 | $137 | $306 |
| Receivables | $14 | $32 | $18 | $16 |
| Inventory | $3 | $2 | $1 | $0 |
| Other Curr. Assets | $7 | $21 | $13 | $9 |
| Total Curr. Assets | $168 | $275 | $224 | $350 |
| Property Plant & Equip (Net) | $31 | $29 | $35 | $27 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $4 | $4 | $3 | $0 |
| Long-Term Investments | $0 | -$4 | -$8 | $0 |
| Tax Assets | $7 | $4 | $5 | $0 |
| Other NC Assets | $9 | $14 | $23 | $22 |
| Total NC Assets | $51 | $47 | $57 | $49 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $219 | $322 | $281 | $399 |
| Liabilities | – | – | – | – |
| Payables | $9 | $10 | $9 | $12 |
| Short-Term Debt | $16 | $8 | $14 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $28 | $35 |
| Other Curr. Liab. | $34 | $24 | $1 | $3 |
| Total Curr. Liab. | $61 | $43 | $52 | $56 |
| LT Debt | $42 | $51 | $44 | $40 |
| Deferred Rev, NC | $10 | $13 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $8 | $6 | $7 | $4 |
| Total NC Liab. | $60 | $70 | $51 | $44 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $121 | $112 | $103 | $100 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $16 | $16 | $13 | $12 |
| Retained Earnings | -$901 | -$750 | -$606 | -$454 |
| AOCI | $26 | $3 | $0 | $2 |
| Other Equity | $957 | $941 | $771 | $738 |
| Total Equity | $98 | $210 | $178 | $299 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $219 | $322 | $281 | $399 |
| Net Debt | -$10 | $4 | $3 | $27 |